Related references
Note: Only part of the references are listed.Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock
Regina Sordi et al.
ANNALS OF SURGERY (2021)
The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease
Roddy Hiram et al.
CARDIOVASCULAR RESEARCH (2021)
Resolvin D1, therapeutic target in acute respiratory distress syndrome
Emad Molaei et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Resolvin D1 Attenuates Innate Immune Reactions in Experimental Subarachnoid Hemorrhage Rat Model
Guang-Jie Liu et al.
MOLECULAR NEUROBIOLOGY (2021)
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages
Antonio Recchiuti et al.
FASEB JOURNAL (2021)
Resolvin D1 Improves the Treg/Th17 Imbalance in Systemic Lupus Erythematosus Through miR-30e-5p
Tao Cheng et al.
FRONTIERS IN IMMUNOLOGY (2021)
Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders
Yong-Hyun Han et al.
BIOMOLECULES & THERAPEUTICS (2021)
Resolvin D1 suppresses inflammation-induced hyperexcitability of nociceptive trigeminal neurons associated with mechanical hyperalgesia
Anjyu Ikeda et al.
BRAIN RESEARCH BULLETIN (2020)
Resolvin D1 Ameliorates Nicotinamide-streptozotocin-induced Type 2 Diabetes Mellitus by its Anti-inflammatory Action and Modulating PI3K/Akt/mTOR Pathway in the Brain
Siresha Bathina et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Resolvin D1 and D2 inhibit tumour growth and inflammation via modulating macrophage polarization
Kai Shan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
15-Epi-LXA4 and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation
Meriem Sekheri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Liver trauma: WSES 2020 guidelines
Federico Coccolini et al.
WORLD JOURNAL OF EMERGENCY SURGERY (2020)
ResolvinD1protects against sepsis-induced cardiac injury in mice
Menglong Wang et al.
BIOFACTORS (2020)
Resolvin D1 Attenuates Lipopolysaccharide Induced Acute Lung Injury Through CXCL-12/CXCR4 Pathway (vol 188, pg 213, 2014)
Wang Yaxin et al.
JOURNAL OF SURGICAL RESEARCH (2020)
Effect of RvD1/FPR2 on inflammatory response in chorioamnionitis
Anna Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Limited potential of resolvin D1 in treatment of cholestatic liver fibrosis
Kerstin Abshagen et al.
HEPATOBILIARY SURGERY AND NUTRITION (2020)
Resolvin D1 mitigates non-alcoholic steatohepatitis by suppressing the TLR4-MyD88-mediated NF-κB and MAPK pathways and activating the Nrf2 pathway in mice
Jiahuan Li et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells
Rebecca Kaye et al.
EXPERIMENTAL EYE RESEARCH (2019)
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne-Carrie et al.
JOURNAL OF HEPATOLOGY (2019)
Resolvin D1 activates the sphingosine-1-phosphate signaling pathway in murine livers with ischemia/reperfusion injury
Jung-Woo Kang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP
Liankang Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Resolvin D1 attenuates ventilator-induced lung injury by reducing HMGB1 release in a HO-1-dependent pathway
Zhipeng Sun et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages
Hua-Wei Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
Xiaoming Bai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease (vol 10, 3945, 2019)
Paraskevi Krashia et al.
NATURE COMMUNICATIONS (2019)
Resolvin D1 attenuates mechanical stretch-induced pulmonary fibrosis via epithelial-mesenchymal transition
Yiyi Yang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2019)
ResolvinD(1) stimulates epithelial wound repair and inhibits TGF-beta-induced EMT whilst reducing fibroproliferation and collagen production
Shengxing Zheng et al.
LABORATORY INVESTIGATION (2018)
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection
M. Codagnone et al.
MUCOSAL IMMUNOLOGY (2018)
Ischemia-Reperfusion Injury in Aged LiversThe Energy Metabolism, Inflammatory Response, and Autophagy
Chunyi Kan et al.
TRANSPLANTATION (2018)
RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells
Xiancai Zhong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Resolvin D1 attenuates liver ischaemia/reperfusion injury through modulating thioredoxin 2-mediated mitochondrial quality control
Jung-Woo Kang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View
Christina C. Lindenmeyer et al.
CLINICS IN LIVER DISEASE (2018)
Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-kappa B in Mice with Septic-Associated Lung Injury
Yuzhen Zhuo et al.
INFLAMMATION (2018)
AT-RVD1 repairs mouse lung after cigarette smoke-induced emphysema via downregulation of oxidative stress by NRF2/KEAP1 pathway
Sara Vergel Posso et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Charles N. Serhan et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies
Laura Pimpin et al.
JOURNAL OF HEPATOLOGY (2018)
Liver fibrosis
M. Merve Aydin et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2018)
Acute Liver Failure An Update
James E. Squires et al.
CLINICS IN LIVER DISEASE (2018)
HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
Qing Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice (vol 7, 45525, 2017)
Ching-Shuen Wang et al.
SCIENTIFIC REPORTS (2018)
Protective effect of aspirin-triggered resolvin D1 on hepatic ischemia/reperfusion injury in rats: The role of miR-146b
Tao Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors
Nan Chiang et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
Olaf Eickmeier et al.
PLOS ONE (2017)
Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC MEDICINE (2017)
Resolvin D1 attenuates CCl4-induced acute liver injury involving up-regulation of HO-1 in mice
Xiahong Chen et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2016)
Resolvin D1 and E1 alleviate the progress of hepatitis toward liver cancer in long-term concanavalin A-induced mice through inhibition of NF-κB activity
Haoyu Kuang et al.
ONCOLOGY REPORTS (2016)
Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis
Jung-Woo Kang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
Tarec K. Elajami et al.
FASEB JOURNAL (2016)
The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis
Houda Benabdoune et al.
INFLAMMATION RESEARCH (2016)
Aspirin-triggered resolvin D1 inhibits TGF-β1-induced EMT through the inhibition of the mTOR pathway by reducing the expression of PKM2 and is closely linked to oxidative stress
Yu Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue
Esther Titos et al.
JOURNAL OF IMMUNOLOGY (2016)
Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis
Lucy V. Norling et al.
JCI INSIGHT (2016)
Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS
Ai Sasaki et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Resolvin D1 protects against hepatic ischemia/reperfusion injury in rats
Tao Zhang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
Vasundhara Kain et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Protection from Endotoxic Uveitis by Intravitreal Resolvin D1: Involvement of Lymphocytes, miRNAs, Ubiquitin-Proteasome, and M1/M2 Macrophages
S. Rossi et al.
MEDIATORS OF INFLAMMATION (2015)
AT-RvD1 Modulates CCL-2 and CXCL-8 Production and NF-κB, STAT-6, SOCS1, and SOCS3 Expression on Bronchial Epithelial Cells Stimulated with IL-4
Jhony Robison de Oliveira et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Mitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion Injury
Kristina L. Go et al.
BIOMED RESEARCH INTERNATIONAL (2015)
17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice
Masakiyo Yatomi et al.
PHYSIOLOGICAL REPORTS (2015)
International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G Protein-Coupled Receptors
Joerg Hamann et al.
PHARMACOLOGICAL REVIEWS (2015)
Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue
Romain A. Colas et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2014)
Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis
Bibiana Rius et al.
FASEB JOURNAL (2014)
The Global Burden of Liver Disease: The Major Impact of China
Fu-Sheng Wang et al.
HEPATOLOGY (2014)
Resolvin D1 Attenuates Polyinosinic-Polycytidylic Acid-Induced Inflammatory Signaling in Human Airway Epithelial Cells via TAK1
Hsi-Min Hsiao et al.
JOURNAL OF IMMUNOLOGY (2014)
Resolvin D1 reduces ER stress-induced apoptosis and triglyceride accumulation through JNK pathway in HepG2 cells
Tae Woo Jung et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Pro-resolving lipid mediators are leads for resolution physiology
Charles N. Serhan
NATURE (2014)
Resolvin D1 protects periodontal ligament
Manal Mustafa et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
Diversity of lipid mediators in human adipose tissue depots
Joan Claria et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2013)
1 alpha,25-Dihydroxyvitamin D-3 and Resolvin D1 Retune the Balance between Amyloid-beta Phagocytosis and Inflammation in Alzheimer's Disease Patients
Mathew T. Mizwicki et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Ischaemia-reperfusion injury, in liver transplantation-from bench to bedside
Yuan Zhai et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation
Hsi-Min Hsiao et al.
PLOS ONE (2013)
Resolvin D1 Receptor Stereoselectivity and Regulation of Inflammation and Proresolving MicroRNAs
Sriram Krishnamoorthy et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Resolvin D1 Limits Polymorphonuclear Leukocyte Recruitment to Inflammatory Loci Receptor-Dependent Actions
Lucy V. Norling et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Resolvin D1 and Aspirin-Triggered Resolvin D1 Promote Resolution of Allergic Airways Responses
Alexandre P. Rogerio et al.
JOURNAL OF IMMUNOLOGY (2012)
Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferation
Xinli Qu et al.
JOURNAL OF PATHOLOGY (2012)
NF-kappa B and STAT3 - key players in liver inflammation and cancer
Guobin He et al.
CELL RESEARCH (2011)
Resolvins and Protectins in Inflammation Resolution
Charles N. Serhan et al.
CHEMICAL REVIEWS (2011)
Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice
Jason Hellmann et al.
FASEB JOURNAL (2011)
Suppressive action of resolvin D1 on the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice
Taisuke Murakami et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
Pathology of Immune-Mediated Liver Injury
Hans-Peter Dienes et al.
DIGESTIVE DISEASES (2010)
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions
Zhen-Zhong Xu et al.
NATURE MEDICINE (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents
Tatjana Haitina et al.
BMC GENOMICS (2009)
Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins
Ana Gonzalez-Periz et al.
FASEB JOURNAL (2009)
Role and significance of focal adhesion proteins in hepatocellular carcinoma
Judy Wai Ping Yam et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus
C. N. Serhan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Diagnosis and therapy of nonalcoholic steatohepatitis
Dawn M. Torres et al.
GASTROENTEROLOGY (2008)
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Angela M. Zivkovic et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Formyl peptide receptors: A promiscuous subfamily of G protein-coupled receptors controlling immune responses
Isabelle Migeotte et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Share Paper
